FIG 3.

Predicted probability of detecting mutant pfmdr1 86Y (A) or pfcrt 76T (B) parasites with increasing piperaquine concentrations for women receiving DHA-PQ with parasitemia. Points are the raw data, showing isolates with mutant (100%) or wild-type (0%) genotypes. (C) Odds of detecting mutant genotypes in the DHA-PQ treatment arms compared to that in the SP arm. The solid lines are the median probabilities or increased odds of detecting a mutant parasite during an episode of parasitemia, and the shading encompasses the probability or increased odds of detecting a mutant parasite for 95% of the population.